Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Celgene
 More »

  • Celgene, Concert in $300M+ Deuterium Drug Collaboration
    Celgene will use Concert Pharmaceuticals' deuterated chemical entity (DCE) Platform® ... In return for using the DCE technology, Celgene agreed to give Concert an up-front ...
    5-6-2013
  • Celgene, Forma Team Up to Develop Protein Homeostasis Drug Candidates
    Forma Therapeutics Holdings and Celgene are collaborating in an effort to discover, ... drug candidates through Phase I, while Celgene will be responsible for all further ...
    4-29-2013
  • GEN | Biolinks
    ... Catholic University of America Cayman Chemical Company Celator Pharmaceuticals Celgene Cell Guidance Systems Cell Therapeutics Celladon Celldex Therapeutics Cellgro by ...
  • Report: Orphan Drugs Cheaper to Bring to Market, Offer Better...
    Roche and Celgene rounded out the top three with $9 billion and $4.9 billion in orphan drug sales, respectively. EvaluatePharma expects Novartis will remain the industry leader ...
    4-22-2013
  • Biosimilars: 10 Drugs to Watch
    ... 2015 in EU; October 2015 in U.S. Neupogen (filgrastim) Drug developers: Biocon and Celgene: Nufil marketed in India by Biocon; in active development for EU by joint venture ...
    4-22-2013
  • bluebird Rides in Celgene CAR T-cells Program
    bio entered a collaboration with Celgene to discover, develop, and commercialize ... and profit sharing rights. Celgene has an option to license any products ...
    3-21-2013
  • Sorrento Boosts Cancer Pipeline with Igdrasol Purchase
    Sorrento Therapeutics said today it signed an exclusive option to acquire oncology drug developer Igdrasol, in a deal the buyer said would strengthen its cancer portfolio by adding ...
    3-7-2013
  • Presage, Celgene Put Heads Together to Find New Cancer Drug Combos
    Presage Biosciences is conspiring with Celgene Corporation in a strategic collaboration ... research and early development at Celgene. "The Presage platform addresses this ...
    3-5-2013
  • FDA Blocks Novo, Boosts Celgene
    FDA delivered bad news to Novo Nordisk and good news to Celgene in separate decisions ... Celgene Wins Pomalyst OK Celgene said the agency approved the company's application to ...
    2-11-2013
  • Top 25 M&A Deals of 2012
    million Deal Completed: Sept. 13 Premium: N/A #14. Avila Therapeutics Acquired by: Celgene Price: $925 million 8 Deal Completed: March 8 Premium: N/A #13. Micromet Acquired by: ...
    1-4-2013
  • Sutro in Up-to-$500M Collaboration with Celgene
    and develop for Celgene new antibody drug conjugates (ADCs) and bispecific antibodies for two undisclosed targets-as well as manufacture a proprietary Celgene antibody-under a ...
    12-18-2012
  • Biotech: A Model of Creative Acquisition
    ... The four companies that were among the top ten in both 2005 and 2011-Amgen, Gilead, Biogen Idec, and Celgene-reported total revenues and total net income of $17 billion and $4.7 ...
    12-1-2012
  • Insider Trading Ring: Two Pharma Execs Charged
    and by actively trading in Celgene stock to create a pattern of long-standing positions. ... ring began in 2007 when Lazorchak left Sanofi, where he had worked with Cupo, for Celgene. ...
    11-20-2012
  • People in the News
    ... Dr. Zeldis is CEO and CMO at Celgene. Previously, he was svp of clinical research and medical affairs. Prior to Celgene, Dr. Zeldis worked at Sandoz and Janssen in clinical ...
    11-1-2012
  • The 10 Most Well-Connected People in Biotech
    ... Archemix Avila Therapeutics, Board of Directors, January 2007-2012; acquired by Celgene in 2012 Ivrea Pharmaceuticals NxStage Medical, Board of Directors, 2005 Prestwick, ...
    10-29-2012

  • Journal Articles

  • Immunomodulatory Drugs (IMiDs) Increase the Production of IL...
    Faribourz Payvandi, Lei Wu, Syedah D. Naziruddin, Maura Haley, Anastasia Parton, Peter H. Schafer, Roger S. Chen, George W. Muller, Christopher C.W. Hughes, David I. Stirling
    Journal of Interferon & Cytokine Research
    In the present study, we investigated the effects of one of the IMiDs, CC-4047 (Actimid(tm), Celgene, Warren, NJ), on synthesis of IL-2 protein and mRNA and on the activity and ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll